2026年全球氧合器市場報告

近年來，氧合器市場發展迅速，預計將從2025年的25.8億美元成長到2026年的28.8億美元，複合年成長率達11.6%。過去幾年的成長歸因於多種因素，例如急性呼吸衰竭病例的增加、心胸外科手術中體外循環技術的早期應用、器官移植數量的增加、膜氧合技術的發展以及體外生命支持的日益普及。

預計未來幾年人工肺市場將快速成長，到2030年市場規模將達到42.7億美元，複合年成長率（CAGR）為10.4%。預測期內的成長要素包括：對重症監護生命支持的需求不斷成長；對攜帶式和小型人工肺系統的關注度日益提高；對先進氧合膜材料的投資不斷增加；在急診和創傷護理領域的應用不斷擴展；以及微創體外支持解決方案的日益普及。預測期內的主要趨勢包括：嚴重呼吸衰竭和重症監護管理領域對人工肺系統的需求不斷成長；複雜心臟和肺移植手術中體外支持設備的廣泛應用；微創和臨時性肺支持作為移植的替代方案越來越受到青睞；用於急診護理的攜帶式和可運輸人工肺裝置不斷發展；以及基於膜的人工肺技術在高效氣體應用和長期支持方面的廣泛發展。

預計未來幾年呼吸系統疾病盛行率的上升將推動人工肺市場的成長。空氣污染加劇、氣候變遷和生活方式改變等因素加劇了呼吸系統疾病帶來的公共衛生負擔。人工肺透過向血液輸送氧氣和清除二氧化碳來補充或取代受損的肺功能。例如，根據澳洲健康與福利研究所 (AIHW) 估計，截至 2024 年 6 月，約有 850 萬澳洲人（佔總人口的 34%）將患有慢性呼吸系統疾病。其中，約有 280 萬人（佔總人口的 11%）將患有氣喘，63.8 萬人（佔總人口的 2.5%）將患有慢性阻塞性肺病(COPD)。呼吸系統疾病盛行率的上升趨勢正在推動人工肺市場的成長。

人工肺市場的主要企業正致力於開發攜帶式體外膜氧合（ECMO）系統等先進解決方案，旨在使體外生命支持能夠應用於加護病房（ICU）以外的領域，加快患者轉運速度，並方便現場部署。攜帶式氣動ECMO系統採用氧氣供應驅動幫浦和整合氣體管理技術，無需外部電源或大型電氣元件即可提供體外氧合和循環支援。例如，2024年5月，德國醫療設備製造商Hemovent GmbH宣布，其全球首款整合式攜帶式氣動ECMO系統MOBYBOX在歐洲首次投入商業性應用。 MOBYBOX重量約2.5公斤，僅依靠氧氣供應即可運行，無需電池或馬達。它採用Bionique Flow技術，可實現更溫和的血液處理並提高氣體交換效率，並已獲得醫療設備法規（MDR）認證，可率先進入市場。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球氧合器市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 工業4.0和智慧製造
  • 數位化、雲端運算、巨量資料、網路安全
  • 人工智慧（AI）和自主人工智慧
  • 物聯網、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 嚴重呼吸衰竭和重症監護管理中對人工肺系統的需求不斷成長
  • 體外輔助裝置在複雜心臟和肺部移植手術的應用日益增多
  • 微創臨時肺部支持技術正日益被用作肺移植的替代方案。
  • 加快開發用於緊急醫療環境的攜帶式、可運輸式氧合器裝置
  • 擴大膜式人工肺技術的應用，以實現高效氣體交換和長期支持

第5章 終端用戶產業市場分析

• 醫院
• 急診中心
• 專業心臟外科中心
• 移植護理單元
• 其他最終用戶

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球氧合器市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球氧合器市場規模、比較及成長率分析
• 全球氧合器市場表現：規模與成長，2020-2025年
• 全球氧合器市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 依產品類型
• 單滾輪泵體外循環機、雙滾輪泵體外循環機、鼓泡式氧合器、膜式氧合器
• 透過使用
• 心臟手術、肺移植手術、急性呼吸衰竭的治療等用途
• 最終用戶
• 醫院、急診中心和其他最終用戶
• 按類型細分：單滾輪泵體外循環機
• 攜帶式式單滾輪幫浦體外循環機，固定式單滾輪幫浦體外循環機
• 依類型細分：雙滾輪幫浦體外循環機
• 攜帶式雙滾輪幫浦體外循環機，固定式雙滾輪幫浦體外循環機
• 依類型細分：鼓泡式增氧機
• 拋棄式氣泡式氧氣機，可重複使用氣泡式氧氣機
• 按類型細分：膜式氧合器
• 膜式氧合器，二氧化碳去除膜式氧合器

第10章 區域與國家分析

• 全球氧合器市場：按地區、性能和預測分類，2020-2025年、2025-2030年預測、2035年預測
• 全球氧合器市場：按國家、性能和預測分類，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 氧合器市場：競爭格局及市場佔有率（2024年）
• 氧合器市場：公司估值矩陣
• 氧合肺市場：公司簡介
  • Getinge AB
  • Medtronic plc
  • LivaNova PLC
  • Terumo Corporation
  • Fresenius Medical Care AG & Co KGaA

第37章：其他領先和創新企業

• ALung Technologies Inc, Xenios AG, Eurosets Srl, Nipro Corporation, Braile Biomedica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年氧合器市場：提供新機會的國家
• 2030年氧合器市場：充滿新機會的細分市場
• 2030年氧合器市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

An artificial lung is a medical device created to assume the function of natural lungs by supplying oxygen to the blood and eliminating carbon dioxide. It is commonly employed in patients experiencing severe respiratory failure or during surgeries where temporary cessation of heart and lung function is necessary. This technology aims to support or replace lung function, facilitating patient survival and recovery from critical conditions.

The primary types of artificial lungs include single roller pump heart-lung machines, double roller pump heart-lung machines, bubble artificial lungs, and membrane artificial lungs. A single roller pump heart-lung machine operates using a single roller pump to circulate blood through an artificial lung and back into the patient during cardiopulmonary bypass surgery. These machines are utilized in cardiac surgery, lung transplants, acute respiratory failure treatments, and other medical procedures, catering to diverse end users such as hospitals, emergency centers, and healthcare facilities.

Tariffs are influencing the artificial lung market by increasing the cost of imported precision components, membranes, pumps, and control electronics used in heart-lung machines and membrane artificial lung systems, thereby raising overall production and procurement costs for hospitals and emergency care facilities. The most affected segments include membrane artificial lung devices and portable roller pump systems, particularly in regions dependent on international sourcing such as Asia-Pacific and Europe. At the same time, tariffs are encouraging near-shore manufacturing, regional assembly, and supplier diversification, which may support innovation and strengthen supply resilience in the long term across artificial lung product segments.

The artificial lung market research report is one of a series of new reports from The Business Research Company that provides artificial lung market statistics, including artificial lung industry global market size, regional shares, competitors with a artificial lung market share, detailed artificial lung market segments, market trends and opportunities, and any further data you may need to thrive in the artificial lung industry. This artificial lung market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial lung market size has grown rapidly in recent years. It will grow from $2.58 billion in 2025 to $2.88 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rise in incidence of acute respiratory failure cases, early adoption of heart lung machines in cardiothoracic surgery, growth in organ transplant procedure volumes, development of membrane artificial lung technology, increasing utilization of extracorporeal life support systems.

The artificial lung market size is expected to see rapid growth in the next few years. It will grow to $4.27 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for critical care life-support devices, growing focus on portable and compact artificial lung systems, rising investment in advanced oxygenation membrane materials, expansion of applications in emergency and trauma care, increasing adoption of minimally invasive extracorporeal support solutions. Major trends in the forecast period include increasing demand for artificial lung systems in severe respiratory failure and critical care management, rising adoption of extracorporeal support devices in complex cardiac and lung transplant surgeries, growing preference for minimally invasive and temporary lung support alternatives to transplantation, increasing development of portable and transport-compatible artificial lung units for emergency care settings, expanding use of membrane-based artificial lung technologies for efficient gas exchange and long-term support.

The rising prevalence of respiratory diseases is expected to drive growth in the artificial lung market in the coming years. Factors such as increasing air pollution, climate change, and lifestyle changes have contributed to a growing burden of respiratory conditions on public health. Artificial lungs are employed to support or replace impaired lung function by providing oxygenation and removing carbon dioxide from the blood. For example, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, approximately 8.5 million Australians, or 34% of the population, were estimated to have chronic respiratory conditions. This includes an estimated 2.8 million people (11% of the population) living with asthma and 638,000 people (2.5% of the population) living with chronic obstructive pulmonary disease (COPD). As a result, the growing prevalence of respiratory diseases is propelling the artificial lung market forward.

Major companies operating in the artificial lung market are focusing on developing advanced solutions, such as portable pneumatic ECMO systems, to extend extracorporeal life support beyond the ICU and facilitate rapid patient transport and field deployment. Portable pneumatic ECMO systems use oxygen-supply-driven pumps and integrated gas management to provide extracorporeal oxygenation and circulatory support without dependence on external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a Germany-based medical device company, announced that MOBYBOX, the world's first integrated portable pneumatic ECMO system, completed its initial commercial applications in Europe. MOBYBOX weighs approximately 2.5 kg, operates solely on oxygen supply without a battery or motor, incorporates Bionique Flow Technology for gentler blood handling and enhanced gas exchange, and has obtained Medical Device Regulation certification for its initial markets.

In August 2024, Getinge AB, a Sweden-based medical technology company, acquired Paragonix Technologies for approximately US$477 million. This acquisition is intended to expand Getinge's organ preservation and transplant logistics portfolio by integrating Paragonix's advanced organ transport and storage systems, thereby improving transplant outcomes and strengthening Getinge's position in cardiac and thoracic transplant workflows. Paragonix Technologies is a US-based company specializing in organ preservation and transport solutions for cardiac and thoracic transplantation.

Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomedica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation

North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial lung market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial lung market consists of sales of extracorporeal membrane oxygenation (ECMO), intravenous membrane oxygenators (IVOX), bioartificial lungs, and microfluidic artificial lungs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Lung Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial lung market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial lung ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial lung market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Single Roller Pump Heart Lung Machines; Double Roller Pump Heart Lungs Machines; Bubble Artificial Lung; Membrane Artificial Lung
• 2) By Application: Cardiac Surgery; Lung Transplant Operation; Acute Respiratory Failure Treatment; Other Applications
• 3) By End-Users: Hospital; Emergency Center; Other End-users
• Subsegments:
• 1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines; Stationary Single Roller Pump Heart Lung Machines
• 2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines; Stationary Double Roller Pump Heart Lung Machines
• 3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung; Reusable Bubble Artificial Lung
• 4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung; Carbon Dioxide Removal Membrane Artificial Lung
• Companies Mentioned: Getinge AB; Medtronic plc; LivaNova PLC; Terumo Corporation; Fresenius Medical Care AG & Co KGaA; ALung Technologies Inc; Xenios AG; Eurosets S.r.l; Nipro Corporation; Braile Biomedica; Hemovent GmbH; MC3 Cardiopulmonary Inc; Abbott Laboratories; Spectrum Medical Ltd; B Braun Melsungen AG; SB-Kawasumi Laboratories Inc; Senko Medical Instrument Mfg Co Ltd; CARMAT; Technowood International Pte Ltd; Elite Lifecare; Cytosorbents Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Artificial Lung Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Artificial Lung Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Artificial Lung Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Artificial Lung Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Demand For Artificial Lung Systems In Severe Respiratory Failure And Critical Care Management
  • 4.2.2 Rising Adoption Of Extracorporeal Support Devices In Complex Cardiac And Lung Transplant Surgeries
  • 4.2.3 Growing Preference For Minimally Invasive And Temporary Lung Support Alternatives To Transplantation
  • 4.2.4 Increasing Development Of Portable And Transport-Compatible Artificial Lung Units For Emergency Care Settings
  • 4.2.5 Expanding Use Of Membrane-Based Artificial Lung Technologies For Efficient Gas Exchange And Long-Term Support

5. Artificial Lung Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Emergency Centers
• 5.3 Specialized Cardiac Surgery Centers
• 5.4 Transplant Care Units
• 5.5 Other End Users

6. Artificial Lung Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Lung Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Artificial Lung PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Artificial Lung Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Artificial Lung Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Artificial Lung Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Lung Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Lung Market Segmentation

• 9.1. Global Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung
• 9.2. Global Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications
• 9.3. Global Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital, Emergency Center, Other End-users
• 9.4. Global Artificial Lung Market, Sub-Segmentation Of Single Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines
• 9.5. Global Artificial Lung Market, Sub-Segmentation Of Double Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines
• 9.6. Global Artificial Lung Market, Sub-Segmentation Of Bubble Artificial Lung, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung
• 9.7. Global Artificial Lung Market, Sub-Segmentation Of Membrane Artificial Lung, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

10. Artificial Lung Market Regional And Country Analysis

• 10.1. Global Artificial Lung Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Artificial Lung Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Lung Market

• 11.1. Asia-Pacific Artificial Lung Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Lung Market

• 12.1. China Artificial Lung Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Lung Market

• 13.1. India Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Lung Market

• 14.1. Japan Artificial Lung Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Lung Market

• 15.1. Australia Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Lung Market

• 16.1. Indonesia Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Lung Market

• 17.1. South Korea Artificial Lung Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Lung Market

• 18.1. Taiwan Artificial Lung Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Lung Market

• 19.1. South East Asia Artificial Lung Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Lung Market

• 20.1. Western Europe Artificial Lung Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Lung Market

• 21.1. UK Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Lung Market

• 22.1. Germany Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Lung Market

• 23.1. France Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Lung Market

• 24.1. Italy Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Lung Market

• 25.1. Spain Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Lung Market

• 26.1. Eastern Europe Artificial Lung Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Lung Market

• 27.1. Russia Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Lung Market

• 28.1. North America Artificial Lung Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Lung Market

• 29.1. USA Artificial Lung Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Lung Market

• 30.1. Canada Artificial Lung Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Lung Market

• 31.1. South America Artificial Lung Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Lung Market

• 32.1. Brazil Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Lung Market

• 33.1. Middle East Artificial Lung Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Lung Market

• 34.1. Africa Artificial Lung Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Lung Market Regulatory and Investment Landscape

36. Artificial Lung Market Competitive Landscape And Company Profiles

• 36.1. Artificial Lung Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Artificial Lung Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Artificial Lung Market Company Profiles
  • 36.3.1. Getinge AB Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Fresenius Medical Care AG & Co KGaA Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Lung Market Other Major And Innovative Companies

• ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomedica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare

38. Global Artificial Lung Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Lung Market

40. Artificial Lung Market High Potential Countries, Segments and Strategies

• 40.1 Artificial Lung Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Artificial Lung Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Artificial Lung Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer